The Oral C5aR Inhibitor INF904 for the Treatment of Chronic Inflammatory Diseases & Beyond

By | 20 January 2026
  • INF904 – C5aR inhibitor with best-in-class potential
  • C5aR inhibition in Hidradenitis Suppurativa
  • C5aR inhibition in Chronic Spontaneous Urticaria